nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—Platinum-containing Compounds—Carboplatin—bone cancer	0.396	1	CiPCiCtD
Cisplatin—GSTP1—bone cancer	0.0888	0.76	CbGaD
Cisplatin—germ cell cancer—bone cancer	0.0735	0.354	CtDrD
Cisplatin—peripheral nervous system neoplasm—bone cancer	0.0678	0.327	CtDrD
Cisplatin—lung cancer—bone cancer	0.0661	0.319	CtDrD
Cisplatin—SLC31A2—Carboplatin—bone cancer	0.0302	0.128	CbGbCtD
Cisplatin—PTGS2—bone cancer	0.0281	0.24	CbGaD
Cisplatin—MT2A—Carboplatin—bone cancer	0.0219	0.0928	CbGbCtD
Cisplatin—ATP7A—Carboplatin—bone cancer	0.0219	0.0928	CbGbCtD
Cisplatin—ATP7B—Carboplatin—bone cancer	0.0219	0.0928	CbGbCtD
Cisplatin—MT1A—Carboplatin—bone cancer	0.0219	0.0928	CbGbCtD
Cisplatin—SOD1—Carboplatin—bone cancer	0.0174	0.0737	CbGbCtD
Cisplatin—SLC31A1—Carboplatin—bone cancer	0.0174	0.0737	CbGbCtD
Cisplatin—GSTT1—Carboplatin—bone cancer	0.0145	0.0616	CbGbCtD
Cisplatin—GSTM1—Carboplatin—bone cancer	0.0126	0.0533	CbGbCtD
Cisplatin—NQO1—Carboplatin—bone cancer	0.00998	0.0423	CbGbCtD
Cisplatin—GSTP1—Carboplatin—bone cancer	0.00908	0.0385	CbGbCtD
Cisplatin—NQO1—Doxorubicin—bone cancer	0.00571	0.0242	CbGbCtD
Cisplatin—XDH—Carboplatin—bone cancer	0.00522	0.0221	CbGbCtD
Cisplatin—MPO—Carboplatin—bone cancer	0.00522	0.0221	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—bone cancer	0.00478	0.0203	CbGbCtD
Cisplatin—XDH—Doxorubicin—bone cancer	0.00299	0.0127	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—bone cancer	0.0023	0.00974	CbGbCtD
Cisplatin—ABCC3—Methotrexate—bone cancer	0.00222	0.00944	CbGbCtD
Cisplatin—ABCC2—Carboplatin—bone cancer	0.00182	0.00773	CbGbCtD
Cisplatin—ABCG2—Carboplatin—bone cancer	0.00165	0.00699	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—bone cancer	0.00104	0.00443	CbGbCtD
Cisplatin—ABCC2—Methotrexate—bone cancer	0.00101	0.00429	CbGbCtD
Cisplatin—ABCG2—Doxorubicin—bone cancer	0.000944	0.004	CbGbCtD
Cisplatin—ABCG2—Methotrexate—bone cancer	0.000914	0.00388	CbGbCtD
Cisplatin—CYP2B6—Doxorubicin—bone cancer	0.000664	0.00281	CbGbCtD
Cisplatin—ABCB1—Doxorubicin—bone cancer	0.00034	0.00144	CbGbCtD
Cisplatin—ABCB1—Methotrexate—bone cancer	0.00033	0.0014	CbGbCtD
Cisplatin—PTGS2—periosteum—bone cancer	0.000163	0.0532	CbGeAlD
Cisplatin—MT1A—connective tissue—bone cancer	0.000162	0.0528	CbGeAlD
Cisplatin—MT2A—connective tissue—bone cancer	0.000135	0.044	CbGeAlD
Cisplatin—PTGS2—leg—bone cancer	0.00013	0.0424	CbGeAlD
Cisplatin—ATP7A—connective tissue—bone cancer	0.000117	0.0381	CbGeAlD
Cisplatin—PTGS2—hindlimb—bone cancer	0.000116	0.0378	CbGeAlD
Cisplatin—PTGS2—cartilage tissue—bone cancer	0.000114	0.0372	CbGeAlD
Cisplatin—ABCC6—connective tissue—bone cancer	0.000107	0.0349	CbGeAlD
Cisplatin—Hypophosphataemia—Doxorubicin—bone cancer	0.000101	0.00447	CcSEcCtD
Cisplatin—PTGS2—appendage—bone cancer	9.97e-05	0.0325	CbGeAlD
Cisplatin—Generalised oedema—Doxorubicin—bone cancer	9.84e-05	0.00437	CcSEcCtD
Cisplatin—GSTM1—connective tissue—bone cancer	9.74e-05	0.0317	CbGeAlD
Cisplatin—Febrile neutropenia—Doxorubicin—bone cancer	9.73e-05	0.00432	CcSEcCtD
Cisplatin—Optic neuritis—Doxorubicin—bone cancer	9.51e-05	0.00423	CcSEcCtD
Cisplatin—Serum creatinine increased—Doxorubicin—bone cancer	9.51e-05	0.00423	CcSEcCtD
Cisplatin—SLC31A2—tendon—bone cancer	9.13e-05	0.0297	CbGeAlD
Cisplatin—MT2A—spinal cord—bone cancer	8.96e-05	0.0292	CbGeAlD
Cisplatin—SLC31A2—bone marrow—bone cancer	8.84e-05	0.0288	CbGeAlD
Cisplatin—SLC31A2—spinal cord—bone cancer	8.8e-05	0.0287	CbGeAlD
Cisplatin—Hepatotoxicity—Methotrexate—bone cancer	8.75e-05	0.00389	CcSEcCtD
Cisplatin—Necrosis—Methotrexate—bone cancer	8.61e-05	0.00383	CcSEcCtD
Cisplatin—Abscess—Methotrexate—bone cancer	8.54e-05	0.00379	CcSEcCtD
Cisplatin—Necrosis—Epirubicin—bone cancer	8.06e-05	0.00358	CcSEcCtD
Cisplatin—ATP7A—tendon—bone cancer	8.04e-05	0.0262	CbGeAlD
Cisplatin—Abscess—Epirubicin—bone cancer	7.99e-05	0.00355	CcSEcCtD
Cisplatin—Ageusia—Epirubicin—bone cancer	7.81e-05	0.00347	CcSEcCtD
Cisplatin—ATP7A—bone marrow—bone cancer	7.79e-05	0.0254	CbGeAlD
Cisplatin—ATP7A—spinal cord—bone cancer	7.76e-05	0.0252	CbGeAlD
Cisplatin—Extravasation—Methotrexate—bone cancer	7.74e-05	0.00344	CcSEcCtD
Cisplatin—Liver injury—Epirubicin—bone cancer	7.52e-05	0.00334	CcSEcCtD
Cisplatin—Necrosis—Doxorubicin—bone cancer	7.45e-05	0.00331	CcSEcCtD
Cisplatin—Abscess—Doxorubicin—bone cancer	7.4e-05	0.00329	CcSEcCtD
Cisplatin—Hyperuricaemia—Methotrexate—bone cancer	7.28e-05	0.00324	CcSEcCtD
Cisplatin—Extravasation—Epirubicin—bone cancer	7.25e-05	0.00322	CcSEcCtD
Cisplatin—Ageusia—Doxorubicin—bone cancer	7.22e-05	0.00321	CcSEcCtD
Cisplatin—Ulcer—Methotrexate—bone cancer	7.14e-05	0.00317	CcSEcCtD
Cisplatin—Dysarthria—Methotrexate—bone cancer	7.14e-05	0.00317	CcSEcCtD
Cisplatin—SOD1—tendon—bone cancer	7.04e-05	0.0229	CbGeAlD
Cisplatin—Cellulitis—Epirubicin—bone cancer	6.95e-05	0.00309	CcSEcCtD
Cisplatin—Liver injury—Doxorubicin—bone cancer	6.95e-05	0.00309	CcSEcCtD
Cisplatin—Blood uric acid increased—Methotrexate—bone cancer	6.88e-05	0.00306	CcSEcCtD
Cisplatin—SLC31A1—tendon—bone cancer	6.86e-05	0.0223	CbGeAlD
Cisplatin—NQO1—connective tissue—bone cancer	6.83e-05	0.0222	CbGeAlD
Cisplatin—SOD1—bone marrow—bone cancer	6.82e-05	0.0222	CbGeAlD
Cisplatin—Hyperuricaemia—Epirubicin—bone cancer	6.82e-05	0.00303	CcSEcCtD
Cisplatin—SOD1—spinal cord—bone cancer	6.79e-05	0.0221	CbGeAlD
Cisplatin—Extravasation—Doxorubicin—bone cancer	6.71e-05	0.00298	CcSEcCtD
Cisplatin—Dysarthria—Epirubicin—bone cancer	6.69e-05	0.00297	CcSEcCtD
Cisplatin—Ulcer—Epirubicin—bone cancer	6.69e-05	0.00297	CcSEcCtD
Cisplatin—SLC31A1—bone marrow—bone cancer	6.64e-05	0.0216	CbGeAlD
Cisplatin—SLC31A1—spinal cord—bone cancer	6.62e-05	0.0215	CbGeAlD
Cisplatin—Skin exfoliation—Methotrexate—bone cancer	6.45e-05	0.00287	CcSEcCtD
Cisplatin—Blood uric acid increased—Epirubicin—bone cancer	6.44e-05	0.00286	CcSEcCtD
Cisplatin—Cellulitis—Doxorubicin—bone cancer	6.43e-05	0.00286	CcSEcCtD
Cisplatin—Hiccups—Epirubicin—bone cancer	6.32e-05	0.00281	CcSEcCtD
Cisplatin—Hepatocellular injury—Epirubicin—bone cancer	6.32e-05	0.00281	CcSEcCtD
Cisplatin—Hyperuricaemia—Doxorubicin—bone cancer	6.31e-05	0.0028	CcSEcCtD
Cisplatin—MPO—connective tissue—bone cancer	6.28e-05	0.0204	CbGeAlD
Cisplatin—Hyperkalaemia—Epirubicin—bone cancer	6.21e-05	0.00276	CcSEcCtD
Cisplatin—Dysarthria—Doxorubicin—bone cancer	6.19e-05	0.00275	CcSEcCtD
Cisplatin—Ulcer—Doxorubicin—bone cancer	6.19e-05	0.00275	CcSEcCtD
Cisplatin—GSTP1—connective tissue—bone cancer	6.1e-05	0.0199	CbGeAlD
Cisplatin—Skin exfoliation—Epirubicin—bone cancer	6.04e-05	0.00268	CcSEcCtD
Cisplatin—Fluid retention—Epirubicin—bone cancer	6e-05	0.00267	CcSEcCtD
Cisplatin—Blood uric acid increased—Doxorubicin—bone cancer	5.96e-05	0.00265	CcSEcCtD
Cisplatin—Neuropathy—Epirubicin—bone cancer	5.94e-05	0.00264	CcSEcCtD
Cisplatin—Hepatocellular injury—Doxorubicin—bone cancer	5.85e-05	0.0026	CcSEcCtD
Cisplatin—Hiccups—Doxorubicin—bone cancer	5.85e-05	0.0026	CcSEcCtD
Cisplatin—Hyperkalaemia—Doxorubicin—bone cancer	5.75e-05	0.00255	CcSEcCtD
Cisplatin—Polyuria—Methotrexate—bone cancer	5.59e-05	0.00248	CcSEcCtD
Cisplatin—Skin exfoliation—Doxorubicin—bone cancer	5.59e-05	0.00248	CcSEcCtD
Cisplatin—Fluid retention—Doxorubicin—bone cancer	5.55e-05	0.00247	CcSEcCtD
Cisplatin—Neuropathy—Doxorubicin—bone cancer	5.49e-05	0.00244	CcSEcCtD
Cisplatin—Phlebitis—Epirubicin—bone cancer	5.33e-05	0.00237	CcSEcCtD
Cisplatin—Renal failure acute—Methotrexate—bone cancer	5.31e-05	0.00236	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Methotrexate—bone cancer	5.07e-05	0.00225	CcSEcCtD
Cisplatin—Cardiac failure congestive—Epirubicin—bone cancer	5.06e-05	0.00225	CcSEcCtD
Cisplatin—ABCC5—tendon—bone cancer	5.02e-05	0.0163	CbGeAlD
Cisplatin—Cerebrovascular accident—Methotrexate—bone cancer	5.01e-05	0.00222	CcSEcCtD
Cisplatin—Renal failure acute—Epirubicin—bone cancer	4.97e-05	0.00221	CcSEcCtD
Cisplatin—Phlebitis—Doxorubicin—bone cancer	4.93e-05	0.00219	CcSEcCtD
Cisplatin—ABCC5—bone marrow—bone cancer	4.86e-05	0.0158	CbGeAlD
Cisplatin—Anaphylactoid reaction—Epirubicin—bone cancer	4.74e-05	0.00211	CcSEcCtD
Cisplatin—NQO1—tendon—bone cancer	4.69e-05	0.0153	CbGeAlD
Cisplatin—Cerebrovascular accident—Epirubicin—bone cancer	4.68e-05	0.00208	CcSEcCtD
Cisplatin—Cardiac failure congestive—Doxorubicin—bone cancer	4.68e-05	0.00208	CcSEcCtD
Cisplatin—Irritability—Methotrexate—bone cancer	4.68e-05	0.00208	CcSEcCtD
Cisplatin—Hyponatraemia—Epirubicin—bone cancer	4.61e-05	0.00205	CcSEcCtD
Cisplatin—Renal failure acute—Doxorubicin—bone cancer	4.6e-05	0.00204	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Epirubicin—bone cancer	4.59e-05	0.00204	CcSEcCtD
Cisplatin—NQO1—spinal cord—bone cancer	4.53e-05	0.0147	CbGeAlD
Cisplatin—Breast disorder—Methotrexate—bone cancer	4.43e-05	0.00197	CcSEcCtD
Cisplatin—Face oedema—Epirubicin—bone cancer	4.43e-05	0.00197	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—bone cancer	4.39e-05	0.00195	CcSEcCtD
Cisplatin—Cerebrovascular accident—Doxorubicin—bone cancer	4.33e-05	0.00193	CcSEcCtD
Cisplatin—Blood creatinine increased—Epirubicin—bone cancer	4.3e-05	0.00191	CcSEcCtD
Cisplatin—Dehydration—Epirubicin—bone cancer	4.27e-05	0.0019	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—bone cancer	4.26e-05	0.00189	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	4.25e-05	0.00189	CcSEcCtD
Cisplatin—GSTP1—tendon—bone cancer	4.19e-05	0.0137	CbGeAlD
Cisplatin—Orthostatic hypotension—Epirubicin—bone cancer	4.19e-05	0.00186	CcSEcCtD
Cisplatin—MPO—bone marrow—bone cancer	4.18e-05	0.0136	CbGeAlD
Cisplatin—Hypokalaemia—Epirubicin—bone cancer	4.18e-05	0.00186	CcSEcCtD
Cisplatin—MPO—spinal cord—bone cancer	4.16e-05	0.0135	CbGeAlD
Cisplatin—Pancreatitis—Methotrexate—bone cancer	4.16e-05	0.00185	CcSEcCtD
Cisplatin—Breast disorder—Epirubicin—bone cancer	4.15e-05	0.00184	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Epirubicin—bone cancer	4.13e-05	0.00184	CcSEcCtD
Cisplatin—Nasopharyngitis—Epirubicin—bone cancer	4.1e-05	0.00182	CcSEcCtD
Cisplatin—Face oedema—Doxorubicin—bone cancer	4.1e-05	0.00182	CcSEcCtD
Cisplatin—Abdominal discomfort—Methotrexate—bone cancer	4.06e-05	0.00181	CcSEcCtD
Cisplatin—GSTP1—bone marrow—bone cancer	4.06e-05	0.0132	CbGeAlD
Cisplatin—GSTP1—spinal cord—bone cancer	4.04e-05	0.0132	CbGeAlD
Cisplatin—Pancytopenia—Methotrexate—bone cancer	4.03e-05	0.00179	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—bone cancer	3.98e-05	0.00177	CcSEcCtD
Cisplatin—Dehydration—Doxorubicin—bone cancer	3.95e-05	0.00176	CcSEcCtD
Cisplatin—Pancreatitis—Epirubicin—bone cancer	3.89e-05	0.00173	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—bone cancer	3.88e-05	0.00172	CcSEcCtD
Cisplatin—Hypokalaemia—Doxorubicin—bone cancer	3.87e-05	0.00172	CcSEcCtD
Cisplatin—Breast disorder—Doxorubicin—bone cancer	3.84e-05	0.00171	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—bone cancer	3.82e-05	0.0017	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—bone cancer	3.8e-05	0.00169	CcSEcCtD
Cisplatin—Pancytopenia—Epirubicin—bone cancer	3.77e-05	0.00167	CcSEcCtD
Cisplatin—Renal failure—Methotrexate—bone cancer	3.72e-05	0.00165	CcSEcCtD
Cisplatin—Stomatitis—Methotrexate—bone cancer	3.68e-05	0.00164	CcSEcCtD
Cisplatin—Conjunctivitis—Methotrexate—bone cancer	3.67e-05	0.00163	CcSEcCtD
Cisplatin—Pancreatitis—Doxorubicin—bone cancer	3.6e-05	0.0016	CcSEcCtD
Cisplatin—Hepatobiliary disease—Methotrexate—bone cancer	3.57e-05	0.00159	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—bone cancer	3.49e-05	0.00155	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—bone cancer	3.48e-05	0.00155	CcSEcCtD
Cisplatin—Neuropathy peripheral—Epirubicin—bone cancer	3.47e-05	0.00154	CcSEcCtD
Cisplatin—Stomatitis—Epirubicin—bone cancer	3.45e-05	0.00153	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—bone cancer	3.44e-05	0.00153	CcSEcCtD
Cisplatin—ABCC2—tendon—bone cancer	3.37e-05	0.011	CbGeAlD
Cisplatin—Urinary tract disorder—Methotrexate—bone cancer	3.35e-05	0.00149	CcSEcCtD
Cisplatin—Hepatobiliary disease—Epirubicin—bone cancer	3.35e-05	0.00149	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—bone cancer	3.33e-05	0.00148	CcSEcCtD
Cisplatin—Visual impairment—Methotrexate—bone cancer	3.27e-05	0.00145	CcSEcCtD
Cisplatin—Bradycardia—Epirubicin—bone cancer	3.23e-05	0.00144	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—bone cancer	3.22e-05	0.00143	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—bone cancer	3.21e-05	0.00143	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—bone cancer	3.19e-05	0.00142	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—bone cancer	3.18e-05	0.00141	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—bone cancer	3.17e-05	0.00141	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—bone cancer	3.16e-05	0.00141	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—bone cancer	3.15e-05	0.0014	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—bone cancer	3.14e-05	0.00139	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—bone cancer	3.12e-05	0.00139	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—bone cancer	3.11e-05	0.00138	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—bone cancer	3.1e-05	0.00138	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—bone cancer	3.07e-05	0.00136	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—bone cancer	3.06e-05	0.00136	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—bone cancer	3.06e-05	0.00136	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—bone cancer	3e-05	0.00133	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—bone cancer	2.99e-05	0.00133	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—bone cancer	2.97e-05	0.00132	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—bone cancer	2.96e-05	0.00132	CcSEcCtD
Cisplatin—Malnutrition—Methotrexate—bone cancer	2.95e-05	0.00131	CcSEcCtD
Cisplatin—Erythema—Methotrexate—bone cancer	2.95e-05	0.00131	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—bone cancer	2.95e-05	0.00131	CcSEcCtD
Cisplatin—Flushing—Epirubicin—bone cancer	2.95e-05	0.00131	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—bone cancer	2.9e-05	0.00129	CcSEcCtD
Cisplatin—CYP4A11—NRF2 pathway—TGFBR2—bone cancer	2.89e-05	0.00163	CbGpPWpGaD
Cisplatin—Connective tissue disorder—Doxorubicin—bone cancer	2.89e-05	0.00128	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—bone cancer	2.88e-05	0.00128	CcSEcCtD
Cisplatin—GSTM1—Metabolism—NDUFA12—bone cancer	2.88e-05	0.00162	CbGpPWpGaD
Cisplatin—Immune system disorder—Epirubicin—bone cancer	2.87e-05	0.00127	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—bone cancer	2.86e-05	0.00127	CcSEcCtD
Cisplatin—PTGS2—connective tissue—bone cancer	2.85e-05	0.00926	CbGeAlD
Cisplatin—SOD1—Cellular responses to stress—GSTP1—bone cancer	2.84e-05	0.0016	CbGpPWpGaD
Cisplatin—Arrhythmia—Epirubicin—bone cancer	2.84e-05	0.00126	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—bone cancer	2.83e-05	0.00126	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—bone cancer	2.81e-05	0.00125	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—bone cancer	2.78e-05	0.00124	CcSEcCtD
Cisplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	2.77e-05	0.00156	CbGpPWpGaD
Cisplatin—Malnutrition—Epirubicin—bone cancer	2.76e-05	0.00123	CcSEcCtD
Cisplatin—Erythema—Epirubicin—bone cancer	2.76e-05	0.00123	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—bone cancer	2.75e-05	0.00122	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—bone cancer	2.74e-05	0.00122	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—bone cancer	2.74e-05	0.00122	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—bone cancer	2.73e-05	0.00121	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—bone cancer	2.73e-05	0.00121	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—bone cancer	2.73e-05	0.00121	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—bone cancer	2.72e-05	0.00121	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—PTGS2—bone cancer	2.7e-05	0.00152	CbGpPWpGaD
Cisplatin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	2.7e-05	0.00152	CbGpPWpGaD
Cisplatin—Malaise—Methotrexate—bone cancer	2.66e-05	0.00118	CcSEcCtD
Cisplatin—Muscle spasms—Epirubicin—bone cancer	2.66e-05	0.00118	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—bone cancer	2.65e-05	0.00118	CcSEcCtD
Cisplatin—SOD1—Folate Metabolism—TP53—bone cancer	2.65e-05	0.00149	CbGpPWpGaD
Cisplatin—Mediastinal disorder—Doxorubicin—bone cancer	2.65e-05	0.00118	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—bone cancer	2.64e-05	0.00117	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—bone cancer	2.62e-05	0.00117	CcSEcCtD
Cisplatin—ABCC5—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.62e-05	0.00147	CbGpPWpGaD
Cisplatin—Vision blurred—Epirubicin—bone cancer	2.61e-05	0.00116	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—bone cancer	2.6e-05	0.00115	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—bone cancer	2.56e-05	0.00114	CcSEcCtD
Cisplatin—Convulsion—Methotrexate—bone cancer	2.56e-05	0.00114	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—bone cancer	2.56e-05	0.00114	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—bone cancer	2.56e-05	0.00114	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—bone cancer	2.56e-05	0.00114	CcSEcCtD
Cisplatin—CYP4A11—Biological oxidations—GSTP1—bone cancer	2.54e-05	0.00143	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—MDM2—bone cancer	2.53e-05	0.00143	CbGpPWpGaD
Cisplatin—Flatulence—Doxorubicin—bone cancer	2.52e-05	0.00112	CcSEcCtD
Cisplatin—Myalgia—Methotrexate—bone cancer	2.51e-05	0.00112	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	2.5e-05	0.00111	CcSEcCtD
Cisplatin—Malaise—Epirubicin—bone cancer	2.49e-05	0.00111	CcSEcCtD
Cisplatin—ABCC3—Fluoropyrimidine Activity—TP53—bone cancer	2.49e-05	0.0014	CbGpPWpGaD
Cisplatin—Discomfort—Methotrexate—bone cancer	2.48e-05	0.0011	CcSEcCtD
Cisplatin—Leukopenia—Epirubicin—bone cancer	2.47e-05	0.0011	CcSEcCtD
Cisplatin—BCHE—bone marrow—bone cancer	2.46e-05	0.00801	CbGeAlD
Cisplatin—Muscle spasms—Doxorubicin—bone cancer	2.46e-05	0.00109	CcSEcCtD
Cisplatin—ABCC3—NRF2 pathway—GSTP1—bone cancer	2.46e-05	0.00138	CbGpPWpGaD
Cisplatin—ABCC3—NRF2 pathway—TGFBR2—bone cancer	2.46e-05	0.00138	CbGpPWpGaD
Cisplatin—BCHE—spinal cord—bone cancer	2.45e-05	0.00797	CbGeAlD
Cisplatin—BCHE—Metabolism of proteins—MOGS—bone cancer	2.45e-05	0.00138	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—NDUFA12—bone cancer	2.45e-05	0.00138	CbGpPWpGaD
Cisplatin—Anaphylactic shock—Methotrexate—bone cancer	2.41e-05	0.00107	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—bone cancer	2.41e-05	0.00107	CcSEcCtD
Cisplatin—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	2.4e-05	0.00135	CbGpPWpGaD
Cisplatin—Convulsion—Epirubicin—bone cancer	2.4e-05	0.00106	CcSEcCtD
Cisplatin—Infection—Methotrexate—bone cancer	2.4e-05	0.00106	CcSEcCtD
Cisplatin—GSTM1—Metabolism—NT5C3A—bone cancer	2.38e-05	0.00134	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—NDUFA12—bone cancer	2.38e-05	0.00134	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—SPARC—bone cancer	2.38e-05	0.00134	CbGpPWpGaD
Cisplatin—ABCG2—bone marrow—bone cancer	2.38e-05	0.00774	CbGeAlD
Cisplatin—Ill-defined disorder—Doxorubicin—bone cancer	2.37e-05	0.00105	CcSEcCtD
Cisplatin—ABCG2—spinal cord—bone cancer	2.37e-05	0.0077	CbGeAlD
Cisplatin—Nervous system disorder—Methotrexate—bone cancer	2.36e-05	0.00105	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—bone cancer	2.36e-05	0.00105	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—bone cancer	2.36e-05	0.00105	CcSEcCtD
Cisplatin—Myalgia—Epirubicin—bone cancer	2.35e-05	0.00105	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—bone cancer	2.35e-05	0.00104	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—bone cancer	2.34e-05	0.00104	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	2.34e-05	0.00104	CcSEcCtD
Cisplatin—Hyperhidrosis—Methotrexate—bone cancer	2.33e-05	0.00104	CcSEcCtD
Cisplatin—Discomfort—Epirubicin—bone cancer	2.33e-05	0.00103	CcSEcCtD
Cisplatin—MPO—Folate Metabolism—TP53—bone cancer	2.31e-05	0.0013	CbGpPWpGaD
Cisplatin—Malaise—Doxorubicin—bone cancer	2.31e-05	0.00102	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—bone cancer	2.3e-05	0.00102	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—bone cancer	2.29e-05	0.00102	CcSEcCtD
Cisplatin—ABCC5—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.26e-05	0.00127	CbGpPWpGaD
Cisplatin—Anaphylactic shock—Epirubicin—bone cancer	2.26e-05	0.001	CcSEcCtD
Cisplatin—Oedema—Epirubicin—bone cancer	2.26e-05	0.001	CcSEcCtD
Cisplatin—Hypotension—Methotrexate—bone cancer	2.25e-05	0.001	CcSEcCtD
Cisplatin—Infection—Epirubicin—bone cancer	2.24e-05	0.000996	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—bone cancer	2.22e-05	0.000985	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—bone cancer	2.21e-05	0.000983	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—bone cancer	2.21e-05	0.000982	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—bone cancer	2.21e-05	0.00124	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—JUN—bone cancer	2.2e-05	0.00124	CbGpPWpGaD
Cisplatin—Tachycardia—Epirubicin—bone cancer	2.2e-05	0.000978	CcSEcCtD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—bone cancer	2.2e-05	0.00124	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Methotrexate—bone cancer	2.2e-05	0.000976	CcSEcCtD
Cisplatin—Skin disorder—Epirubicin—bone cancer	2.19e-05	0.000974	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—bone cancer	2.18e-05	0.000969	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—bone cancer	2.18e-05	0.000968	CcSEcCtD
Cisplatin—SOD1—Hemostasis—GNA11—bone cancer	2.18e-05	0.00122	CbGpPWpGaD
Cisplatin—Anxiety—Doxorubicin—bone cancer	2.17e-05	0.000964	CcSEcCtD
Cisplatin—Paraesthesia—Methotrexate—bone cancer	2.16e-05	0.000962	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	2.16e-05	0.000961	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—bone cancer	2.15e-05	0.000956	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—bone cancer	2.15e-05	0.000956	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—bone cancer	2.15e-05	0.000955	CcSEcCtD
Cisplatin—XDH—Metabolism—NDUFA12—bone cancer	2.14e-05	0.0012	CbGpPWpGaD
Cisplatin—Hypotension—Epirubicin—bone cancer	2.11e-05	0.000937	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—bone cancer	2.1e-05	0.000931	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—bone cancer	2.09e-05	0.000928	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—bone cancer	2.09e-05	0.000928	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—bone cancer	2.08e-05	0.000925	CcSEcCtD
Cisplatin—Infection—Doxorubicin—bone cancer	2.07e-05	0.000922	CcSEcCtD
Cisplatin—Pain—Methotrexate—bone cancer	2.06e-05	0.000916	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—CDK4—bone cancer	2.06e-05	0.00116	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Epirubicin—bone cancer	2.06e-05	0.000913	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—RB1—bone cancer	2.05e-05	0.00115	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—NDUFA12—bone cancer	2.05e-05	0.00115	CbGpPWpGaD
Cisplatin—Nervous system disorder—Doxorubicin—bone cancer	2.05e-05	0.00091	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—bone cancer	2.04e-05	0.000908	CcSEcCtD
Cisplatin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	2.04e-05	0.00115	CbGpPWpGaD
Cisplatin—Tachycardia—Doxorubicin—bone cancer	2.04e-05	0.000905	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—bone cancer	2.03e-05	0.000901	CcSEcCtD
Cisplatin—GSTP1—Metabolism—NT5C3A—bone cancer	2.03e-05	0.00114	CbGpPWpGaD
Cisplatin—Paraesthesia—Epirubicin—bone cancer	2.03e-05	0.0009	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—bone cancer	2.02e-05	0.000897	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—bone cancer	2.01e-05	0.000894	CcSEcCtD
Cisplatin—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	2.01e-05	0.00113	CbGpPWpGaD
Cisplatin—Anorexia—Doxorubicin—bone cancer	1.99e-05	0.000884	CcSEcCtD
Cisplatin—Feeling abnormal—Methotrexate—bone cancer	1.99e-05	0.000883	CcSEcCtD
Cisplatin—NQO1—Metabolism—NT5C3A—bone cancer	1.97e-05	0.00111	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—IL3—bone cancer	1.97e-05	0.00111	CbGpPWpGaD
Cisplatin—Decreased appetite—Epirubicin—bone cancer	1.96e-05	0.000871	CcSEcCtD
Cisplatin—PTGS2—tendon—bone cancer	1.96e-05	0.00637	CbGeAlD
Cisplatin—Hypotension—Doxorubicin—bone cancer	1.95e-05	0.000867	CcSEcCtD
Cisplatin—ABCC2—NRF2 pathway—GSTP1—bone cancer	1.95e-05	0.0011	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—TGFBR2—bone cancer	1.95e-05	0.0011	CbGpPWpGaD
Cisplatin—Gastrointestinal disorder—Epirubicin—bone cancer	1.95e-05	0.000866	CcSEcCtD
Cisplatin—ABCC3—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.93e-05	0.00109	CbGpPWpGaD
Cisplatin—Pain—Epirubicin—bone cancer	1.93e-05	0.000857	CcSEcCtD
Cisplatin—Body temperature increased—Methotrexate—bone cancer	1.91e-05	0.000847	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—bone cancer	1.9e-05	0.000845	CcSEcCtD
Cisplatin—PTGS2—bone marrow—bone cancer	1.89e-05	0.00617	CbGeAlD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	1.89e-05	0.00106	CbGpPWpGaD
Cisplatin—PTGS2—spinal cord—bone cancer	1.89e-05	0.00614	CbGeAlD
Cisplatin—Paraesthesia—Doxorubicin—bone cancer	1.87e-05	0.000833	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—bone cancer	1.86e-05	0.000827	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—bone cancer	1.86e-05	0.000826	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—bone cancer	1.81e-05	0.000806	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—bone cancer	1.8e-05	0.000801	CcSEcCtD
Cisplatin—GSTP1—Cellular responses to stress—CDK4—bone cancer	1.8e-05	0.00101	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—RB1—bone cancer	1.79e-05	0.00101	CbGpPWpGaD
Cisplatin—Pain—Doxorubicin—bone cancer	1.79e-05	0.000793	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—bone cancer	1.78e-05	0.000793	CcSEcCtD
Cisplatin—CYP4A11—Metabolism—NDUFA12—bone cancer	1.78e-05	0.001	CbGpPWpGaD
Cisplatin—Hypersensitivity—Methotrexate—bone cancer	1.78e-05	0.000789	CcSEcCtD
Cisplatin—XDH—Metabolism—NT5C3A—bone cancer	1.77e-05	0.000996	CbGpPWpGaD
Cisplatin—Asthenia—Methotrexate—bone cancer	1.73e-05	0.000769	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	1.73e-05	0.000973	CbGpPWpGaD
Cisplatin—Feeling abnormal—Doxorubicin—bone cancer	1.72e-05	0.000764	CcSEcCtD
Cisplatin—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	1.72e-05	0.000966	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—NT5C3A—bone cancer	1.7e-05	0.000955	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.67e-05	0.000938	CbGpPWpGaD
Cisplatin—Hypersensitivity—Epirubicin—bone cancer	1.66e-05	0.000739	CcSEcCtD
Cisplatin—MT2A—Immune System—ATF1—bone cancer	1.66e-05	0.000932	CbGpPWpGaD
Cisplatin—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	1.65e-05	0.00093	CbGpPWpGaD
Cisplatin—Body temperature increased—Doxorubicin—bone cancer	1.65e-05	0.000733	CcSEcCtD
Cisplatin—Diarrhoea—Methotrexate—bone cancer	1.65e-05	0.000733	CcSEcCtD
Cisplatin—GSTT1—Metabolism—ENO2—bone cancer	1.62e-05	0.000911	CbGpPWpGaD
Cisplatin—Asthenia—Epirubicin—bone cancer	1.62e-05	0.000719	CcSEcCtD
Cisplatin—MT2A—Immune System—IL3—bone cancer	1.61e-05	0.000909	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—RB1—bone cancer	1.56e-05	0.000878	CbGpPWpGaD
Cisplatin—Diarrhoea—Epirubicin—bone cancer	1.54e-05	0.000686	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—bone cancer	1.54e-05	0.000683	CcSEcCtD
Cisplatin—Vomiting—Methotrexate—bone cancer	1.53e-05	0.000681	CcSEcCtD
Cisplatin—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.53e-05	0.000862	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—MDM2—bone cancer	1.53e-05	0.000858	CbGpPWpGaD
Cisplatin—Rash—Methotrexate—bone cancer	1.52e-05	0.000675	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—bone cancer	1.52e-05	0.000675	CcSEcCtD
Cisplatin—ABCC3—Metabolism—NDUFA12—bone cancer	1.51e-05	0.00085	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—DHFR—bone cancer	1.5e-05	0.000845	CbGpPWpGaD
Cisplatin—Asthenia—Doxorubicin—bone cancer	1.5e-05	0.000666	CcSEcCtD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	1.5e-05	0.000842	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	1.49e-05	0.00084	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—NT5C3A—bone cancer	1.47e-05	0.000828	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	1.47e-05	0.000827	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—TP53—bone cancer	1.45e-05	0.000818	CbGpPWpGaD
Cisplatin—Vomiting—Epirubicin—bone cancer	1.43e-05	0.000637	CcSEcCtD
Cisplatin—Nausea—Methotrexate—bone cancer	1.43e-05	0.000636	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—bone cancer	1.43e-05	0.000635	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	1.42e-05	0.0008	CbGpPWpGaD
Cisplatin—Rash—Epirubicin—bone cancer	1.42e-05	0.000632	CcSEcCtD
Cisplatin—Dermatitis—Epirubicin—bone cancer	1.42e-05	0.000632	CcSEcCtD
Cisplatin—GSTT1—Metabolism—GNA11—bone cancer	1.4e-05	0.00079	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—KIT—bone cancer	1.37e-05	0.000772	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—TUBB4B—bone cancer	1.34e-05	0.000755	CbGpPWpGaD
Cisplatin—Nausea—Epirubicin—bone cancer	1.34e-05	0.000595	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	1.34e-05	0.000753	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.33e-05	0.00075	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—MDM2—bone cancer	1.33e-05	0.000749	CbGpPWpGaD
Cisplatin—Vomiting—Doxorubicin—bone cancer	1.33e-05	0.00059	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—JUN—bone cancer	1.33e-05	0.000746	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.32e-05	0.000744	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.32e-05	0.000742	CbGpPWpGaD
Cisplatin—Rash—Doxorubicin—bone cancer	1.32e-05	0.000585	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—bone cancer	1.32e-05	0.000584	CcSEcCtD
Cisplatin—SOD1—Hemostasis—PLAU—bone cancer	1.29e-05	0.000728	CbGpPWpGaD
Cisplatin—CYP2B6—Biological oxidations—CYP3A4—bone cancer	1.27e-05	0.000717	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—CYP3A4—bone cancer	1.27e-05	0.000716	CbGpPWpGaD
Cisplatin—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	1.26e-05	0.000707	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NT5C3A—bone cancer	1.25e-05	0.000704	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	1.25e-05	0.000703	CbGpPWpGaD
Cisplatin—Nausea—Doxorubicin—bone cancer	1.24e-05	0.000551	CcSEcCtD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	1.23e-05	0.000689	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	1.22e-05	0.000686	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	1.2e-05	0.000676	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	1.2e-05	0.000673	CbGpPWpGaD
Cisplatin—ABCB1—bone marrow—bone cancer	1.17e-05	0.00382	CbGeAlD
Cisplatin—ABCB1—spinal cord—bone cancer	1.17e-05	0.0038	CbGeAlD
Cisplatin—BCHE—Metabolism of proteins—TUBB2A—bone cancer	1.16e-05	0.000652	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—JUN—bone cancer	1.16e-05	0.000651	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NDUFA12—bone cancer	1.15e-05	0.000649	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.15e-05	0.000647	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.14e-05	0.00064	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CDK4—bone cancer	1.11e-05	0.000625	CbGpPWpGaD
Cisplatin—CYP2B6—Biological oxidations—GSTP1—bone cancer	1.09e-05	0.000613	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—GSTP1—bone cancer	1.09e-05	0.000613	CbGpPWpGaD
Cisplatin—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	1.07e-05	0.000605	CbGpPWpGaD
Cisplatin—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	1.04e-05	0.000588	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ENO2—bone cancer	1.04e-05	0.000587	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	1.04e-05	0.000586	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NDUFA12—bone cancer	1.04e-05	0.000586	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NDUFA12—bone cancer	1.03e-05	0.00058	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	1.02e-05	0.000573	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—DHFR—bone cancer	9.68e-06	0.000545	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—RB1—bone cancer	9.66e-06	0.000543	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NT5C3A—bone cancer	9.56e-06	0.000538	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	9.49e-06	0.000534	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KIT—bone cancer	9.42e-06	0.00053	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—BRAF—bone cancer	9.36e-06	0.000527	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GNA11—bone cancer	9.05e-06	0.000509	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ENO2—bone cancer	8.88e-06	0.0005	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ENO2—bone cancer	8.88e-06	0.000499	CbGpPWpGaD
Cisplatin—CYP2C9—Biological oxidations—CYP3A4—bone cancer	8.78e-06	0.000494	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—bone cancer	8.75e-06	0.000492	CbGpPWpGaD
Cisplatin—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	8.66e-06	0.000487	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ENO2—bone cancer	8.65e-06	0.000487	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	8.64e-06	0.000486	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NT5C3A—bone cancer	8.63e-06	0.000486	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NT5C3A—bone cancer	8.54e-06	0.000481	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.52e-06	0.000479	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	8.36e-06	0.00047	CbGpPWpGaD
Cisplatin—ABCC5—Disease—DHFR—bone cancer	8.24e-06	0.000464	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—DHFR—bone cancer	8.23e-06	0.000463	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CYP3A4—bone cancer	8.21e-06	0.000462	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—EIF2S1—bone cancer	8.08e-06	0.000454	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.08e-06	0.000454	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—DHFR—bone cancer	8.02e-06	0.000451	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NDUFA12—bone cancer	7.94e-06	0.000447	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—MDM2—bone cancer	7.84e-06	0.000441	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ENO2—bone cancer	7.76e-06	0.000436	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GNA11—bone cancer	7.7e-06	0.000433	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—bone cancer	7.64e-06	0.00043	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NDUFA12—bone cancer	7.64e-06	0.00043	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	7.56e-06	0.000425	CbGpPWpGaD
Cisplatin—CYP2C9—Biological oxidations—GSTP1—bone cancer	7.51e-06	0.000422	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GNA11—bone cancer	7.5e-06	0.000422	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ENO2—bone cancer	7.44e-06	0.000418	CbGpPWpGaD
Cisplatin—MT2A—Immune System—MDM2—bone cancer	7.42e-06	0.000418	CbGpPWpGaD
Cisplatin—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.4e-06	0.000417	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.22e-06	0.000406	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.2e-06	0.000405	CbGpPWpGaD
Cisplatin—XDH—Metabolism—DHFR—bone cancer	7.2e-06	0.000405	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—BRAF—bone cancer	7.17e-06	0.000404	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GSTP1—bone cancer	7.02e-06	0.000395	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	7.01e-06	0.000394	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CYP3A4—bone cancer	6.98e-06	0.000393	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MMP9—bone cancer	6.96e-06	0.000392	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—DHFR—bone cancer	6.9e-06	0.000388	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CYP3A4—bone cancer	6.8e-06	0.000383	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GNA11—bone cancer	6.73e-06	0.000378	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NT5C3A—bone cancer	6.58e-06	0.00037	CbGpPWpGaD
Cisplatin—MT2A—Immune System—JUN—bone cancer	6.45e-06	0.000363	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GNA11—bone cancer	6.45e-06	0.000363	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ENO2—bone cancer	6.45e-06	0.000363	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—BRAF—bone cancer	6.41e-06	0.00036	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NT5C3A—bone cancer	6.33e-06	0.000356	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.22e-06	0.00035	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CYP3A4—bone cancer	6.1e-06	0.000343	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—MDM2—bone cancer	6.01e-06	0.000338	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—DHFR—bone cancer	5.98e-06	0.000337	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFBR2—bone cancer	5.97e-06	0.000336	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CYP3A4—bone cancer	5.85e-06	0.000329	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GSTP1—bone cancer	5.81e-06	0.000327	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTGS2—bone cancer	5.64e-06	0.000317	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NDUFA12—bone cancer	5.63e-06	0.000317	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—EGFR—bone cancer	5.63e-06	0.000317	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.6e-06	0.000315	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GNA11—bone cancer	5.59e-06	0.000315	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ENO2—bone cancer	5.48e-06	0.000308	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—MDM2—bone cancer	5.37e-06	0.000302	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.36e-06	0.000301	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NDUFA12—bone cancer	5.26e-06	0.000296	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GSTP1—bone cancer	5.22e-06	0.000293	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—bone cancer	5.2e-06	0.000293	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—DHFR—bone cancer	5.09e-06	0.000286	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EGFR—bone cancer	5.07e-06	0.000285	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CYP3A4—bone cancer	5.07e-06	0.000285	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.04e-06	0.000284	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GSTP1—bone cancer	5e-06	0.000281	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.87e-06	0.000274	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GNA11—bone cancer	4.75e-06	0.000267	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—bone cancer	4.72e-06	0.000266	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NT5C3A—bone cancer	4.67e-06	0.000263	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NT5C3A—bone cancer	4.36e-06	0.000245	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GSTP1—bone cancer	4.34e-06	0.000244	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP3A4—bone cancer	4.31e-06	0.000242	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.29e-06	0.000241	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ENO2—bone cancer	4.19e-06	0.000236	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KIT—bone cancer	4.07e-06	0.000229	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.97e-06	0.000223	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—DHFR—bone cancer	3.89e-06	0.000219	CbGpPWpGaD
Cisplatin—ABCC5—Disease—BRAF—bone cancer	3.83e-06	0.000215	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.83e-06	0.000215	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.83e-06	0.000215	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ENO2—bone cancer	3.78e-06	0.000213	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ENO2—bone cancer	3.74e-06	0.00021	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSTP1—bone cancer	3.69e-06	0.000207	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—bone cancer	3.64e-06	0.000205	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GNA11—bone cancer	3.63e-06	0.000204	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—DHFR—bone cancer	3.51e-06	0.000197	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—DHFR—bone cancer	3.47e-06	0.000195	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.45e-06	0.000194	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ENO2—bone cancer	3.44e-06	0.000194	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MMP2—bone cancer	3.3e-06	0.000186	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP3A4—bone cancer	3.29e-06	0.000185	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GNA11—bone cancer	3.28e-06	0.000184	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.28e-06	0.000184	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GNA11—bone cancer	3.24e-06	0.000183	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.21e-06	0.000181	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MDM2—bone cancer	3.21e-06	0.000181	CbGpPWpGaD
Cisplatin—PTGS2—Disease—DHFR—bone cancer	3.19e-06	0.00018	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—bone cancer	3.09e-06	0.000174	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—bone cancer	3.09e-06	0.000174	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—bone cancer	3.01e-06	0.000169	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP3A4—bone cancer	2.97e-06	0.000167	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP3A4—bone cancer	2.94e-06	0.000165	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ENO2—bone cancer	2.88e-06	0.000162	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTP1—bone cancer	2.82e-06	0.000158	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ENO2—bone cancer	2.77e-06	0.000156	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.71e-06	0.000153	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—bone cancer	2.7e-06	0.000152	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—DHFR—bone cancer	2.67e-06	0.00015	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—bone cancer	2.59e-06	0.000146	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—DHFR—bone cancer	2.57e-06	0.000145	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTP1—bone cancer	2.54e-06	0.000143	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTP1—bone cancer	2.52e-06	0.000142	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GNA11—bone cancer	2.5e-06	0.000141	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GNA11—bone cancer	2.4e-06	0.000135	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFBR2—bone cancer	2.31e-06	0.00013	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.28e-06	0.000128	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP3A4—bone cancer	2.27e-06	0.000128	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—bone cancer	2.25e-06	0.000126	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—bone cancer	2.19e-06	0.000123	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP3A4—bone cancer	2.18e-06	0.000123	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ENO2—bone cancer	2.04e-06	0.000115	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTP1—bone cancer	1.94e-06	0.000109	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—bone cancer	1.91e-06	0.000107	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ENO2—bone cancer	1.91e-06	0.000107	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—DHFR—bone cancer	1.9e-06	0.000107	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTP1—bone cancer	1.86e-06	0.000105	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GNA11—bone cancer	1.77e-06	9.97e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—DHFR—bone cancer	1.77e-06	9.97e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNA11—bone cancer	1.66e-06	9.31e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP3A4—bone cancer	1.61e-06	9.04e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KIT—bone cancer	1.58e-06	8.89e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP3A4—bone cancer	1.5e-06	8.44e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.49e-06	8.4e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BRAF—bone cancer	1.48e-06	8.35e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—bone cancer	1.46e-06	8.21e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTP1—bone cancer	1.37e-06	7.73e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—bone cancer	1.32e-06	7.41e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—bone cancer	1.3e-06	7.33e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTP1—bone cancer	1.28e-06	7.22e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MDM2—bone cancer	1.24e-06	7e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—bone cancer	9.65e-07	5.43e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—bone cancer	8.5e-07	4.78e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—bone cancer	7.12e-07	4.01e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—bone cancer	6.65e-07	3.74e-05	CbGpPWpGaD
